Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 16Stomach Neoplasms 8Rectal Neoplasms 8Colorectal Neoplasms 7Triple Negative Breast Neoplasms 6Neoplasm Metastasis 6Adenocarcinoma Of Esophagus 6Adenocarcinoma 6Parkinson Disease 4, Autosomal Dominant Lewy Body 4Pancreatic Neoplasms 4Esophageal Neoplasms 4Nasopharyngeal Carcinoma 3Esophageal Squamous Cell Carcinoma 2Carcinoma 2Biliary Tract Neoplasms 2Anus Neoplasms 2Advanced Solid Tumour 2Solid Tumors 1Peritoneal Neoplasms 1Neoplasms 1HIV Infections 1HER2-positive Gastric Cancer 1HER2-positive Breast Cancer 1Colorectal Cancer Metastatic 1Colonic Neoplasms 1Clinical Stage I Gastric Cancer AJCC v8 1Clinical Stage I Esophageal Adenocarcinoma AJCC v8 1Anal Canal Carcinoma 1

Interventions

dehydroftorafur 1Taxes 1Specimen Handling 1Radiotherapy, Intensity-Modulated 1Protons 1Proton Therapy 1Paclitaxel 1Oxaliplatin 1Magnetic Resonance Spectroscopy 1Leucovorin 1Fluorouracil 1Esophagectomy 1Docetaxel 1Carboplatin 1Capecitabine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Clinical Stage I Esophageal Adenocarcinoma AJCC v8 × Capecitabine × 30 days × Clear all
NCT03801876 2026-05-07

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

NRG Oncology

Phase 3 Recruiting
300 enrolled
Gastrointestinal

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Data powered by HemOnc (CC BY 4.0) Colophon âš¡